Concepedia

Author

Mathias Werner

Helios Hospital Berlin-BuchORCID

Also Known As

Burkhard Gess, M Werner, M. Werner, Mathias Werner, Werner, Mathias

115

Publications

3.9K

Citations

26

H-Index

35

Concepts

All Affiliations

Helios Hospital Berlin-BuchUniversität HamburgHelios Klinikum Emil von BehringUniversity Medical Center Hamburg-EppendorfUniversity Hospital Münster
MW

About

Mathias Werner is an author at Helios Hospital Berlin-Buch specializing in medicine, orthopaedics, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

936

2

Health Sciences

2

2

39

3

Anatomy

1

1

28

4

Cell Biology

1

1

16

5

Immunology

1

1

16

Mathias Werner

×

36

Publications

2.8K

Citations

22

H-Index

YearCitations

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Neyssa Marina, Sigbjørn Smeland, Stefan Bielack,

The Lancet Oncology

2016

511

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan,

Journal of Clinical Oncology

2015

412

Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

N. Fuchs, Stefan Bielack, D. Epler,

Annals of Oncology

1998

346

Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

M. Schulte, D. Brecht‐Krauss, Mathias Werner,

PubMed

1999

205

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

Dimosthenis Andreou, Stefan Bielack, D. Carrle,

Annals of Oncology

2010

150

Survival and prognostic factors in chondrosarcoma

Dimosthenis Andreou, S. Ruppin, S. Fehlberg,

Acta Orthopaedica

2011

145

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

Stefano Ferrari, Stefan Bielack, Sigbjørn Smeland,

Tumori Journal

2017

119

Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients

Lisa Marie Kelley, M. Schlegel, Stefanie Hecker‐Nolting,

Journal of Clinical Oncology

2020

88

Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread—results of a large prospective trial

Dimosthenis Andreou, Henrike Boldt, Mathias Werner,

Annals of Oncology

2013

75

Gsα gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma

K. Pollandt, C.C. Engels, E. Kaiser,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2001

62

Page 1